Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
9 minute read
  • Cannabis
  • General
  • Markets
  • News
  • Penny Stocks
  • Politics
  • Small Cap

From Snoop Dogg Video Blasting Trump To GOP Admitting Legal Weed Undercuts Drug Cartels: Benzinga’s Most-Read Pot Stories Of 2023

By Nina Zdinjak
December 28, 10:54 AM
What was the most exciting cannabis news of 2023? 

ALEAF

Read More
2 minute read
  • Asset Sales
  • Cannabis
  • Markets
  • News

Toronto Weed Producer Announces Successful Bidder For Sale And Investment Process

By Jelena Martinovic
October 12, 11:33 PM
Aleafia Health Inc. (OTCQB: ALEAF) (TSX: AH) announced on Thursday that Red White & Bloom Brands Inc.

ALEAF

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Aleafia Health Obtains Creditor Protection To Pursue Restructuring And Sale Process

By Vuk Zdinjak
July 25, 10:25 AM
Red White & Bloom Brands Inc. (OTCEM:RWBYF) (CSE:RWB) provided an update on the indebtedness of Aleafia Health Inc. (OTCQB: ALEAF) (TSX:AH) and certain of its affiliates in connection with the loan agreement made as of December 24, 2021, as amended on

ALEAF

Read More
3 minute read
  • Cannabis
  • M&A
  • Markets
  • News
  • Penny Stocks

Shareholders Of This Pot Stock Say No Acquisition By Red White & Bloom

By Vuk Zdinjak
July 17, 7:53 AM
Red White & Bloom Brands Inc. (OTCEM:RWBYF) (CSE:RWB) and Aleafia Health Inc. (OTCQB: ALEAF) (TSX:AH) announced the mutual termination of the binding letter agreement entered into between the parties on June 6, 2023 in respect of the proposed business combinatio

ALE

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Aleafia Health FY23 Revenue Stagnates, What About Profit?

By Vuk Zdinjak
June 14, 10:45 AM
Aleafia Health Inc. (OTCQB: ALEAF) (TSX:AH) released its audited financial results for the three and twelve months ended March 31, 2023, revealing net revenue of CA$42.8 million ($32.2 million), a decrease of 0.6% compared to CA$43.1 million in FY 2022.

ALEAF

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

This Marijuana Stock Takes A Dive Following Breach Of Financial Covenants Under Its Loan Agreement

By Vuk Zdinjak
May 25, 10:51 AM
Aleafia Health Inc. (OTCQB: ALEAF) (TSX:AH) has entered into an amendment to the terms of the loan agreement with NE SPC II LP dated as of December 24, 2021 and as previously amended by agreements dated March 28, 2022 and June 17, 2022.

ALEAF

Read More
5 minute read
  • Cannabis
  • Exclusives
  • General
  • Government
  • Markets
  • News
  • Penny Stocks
  • Regulations
  • Small Cap
  • Topics

Cannabis Goes Global: Here’s What You Need To Know To Avoid A Bad Case Of FOMO

By Jelena Martinovic
April 5, 2:53 PM
Cannabis legalization has been a major focus of debate in recent years in the U.S. Now the conversation is taking place on a global scale as more countries consider the potential benefits of the policy change.

ACB

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Cantor Fitzgerald Maintains Neutral on Aleafia Health, Raises Price Target to C$0.09

By Benzinga Newsdesk
August 12, 5:09 AM
Cantor Fitzgerald analyst Pablo Zuanic maintains Aleafia Health (TSX:AH) with a Neutral and raises the price target from C$0.08 to C$0.09.

TSX:AH

Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service